Making Pharmacovigilance Work: Key steps for implementing a proactive, business-critical safety model

Date: 6/5/2008
Length: 00:06:29
Thought Leaders: Uwe Maennl, M.D., Ph.D., VP and Worldwide Head of Pharmacovigilance, PAREXEL International and Gadi Saarony, Corporate VP and Worldwide Head, PAREXEL Consulting

In this episode, Dr. Maennl and Mr. Saarony discuss a new safety model for pharmacovigilance, including risk management, key stakeholders, and performance benchmarks to this new approach.

Go to video

Part of the PharmnaVOICE Industry Vision Series